Digital
20 -21 May 2020

MarketsandMarkets Virtual Conference on Liquid Biopsy ( Time Zone - CENTRAL EUROPEAN TIME (CET)

Understanding the potential of liquid biopsies

The advancement of delicate CTC and cfDNA identification led to innovations that has empowered the improvement of liquid biopsies with numerous clinical applications, including-screening for nearness of disease, patient stratification and treatment determination, monitoring treatment reaction and early diagnostics.

MarketsandMarkets Virtual Conference on Liquid Biopsy will unite the pioneers from Diagnostics organization, Experts from Pharmaceutical and Bio-Pharma companies, Researchers and professors from renowned universities to address the challenges in early detection of tumor cells and the potential of liquid biopsies to screen, monitor and treatment of the diseases.

WHAT TO EXPECT

Key Highlights

  • Identification of circulating biomarkers for early diagnosis
  • Challenges and advantages to the end-users
  • Advancement in treatment and monitoring of cancer
  • Clinical and non-clinical application of liquid biopsy
  • Recent developments in assays for liquid biopsy
  • Incorporation of Artificial intelligence and machine learning in liquid biopsy

 

Who Should Attend?

Hospitals- Diagnostics Department, Department of clinical oncology, Pathology Labs

Designation- Oncologist, Immunologist, Hematologist, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors

Universities: Designation- Professors, Researchers, Associate professors in Cancer study

Pharma/Therapeutics: Designation- CEO, COO, Senior scientist in cancer and immunology, Research scientist in cancer, Personalized medicine individuals

Why Attend?

  • Best networking opportunities with industrial experts from all around the world
  • 100+ experts attending
  • Interactive panel discussions with pioneers of the field
  • Platform to showcase/exhibit innovative technologies
  • Expand on existing organizations and make new networks with across industry and the scholarly community

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Karl J. DSilva
Karl J. DSilva
Medical Director, Clinical Asst. Professor of Medicine, Tufts University School of Medicine, Lahey Hospitals and Medical Center
Dana E. Connors
Dana E. Connors
Senior Scientific Project Manager, Cancer Foundation for the National Institutes of Health
Emmanouil Karteris
Emmanouil Karteris
Head of CBCEL, Brunel University London, UK
Antony Newton
Antony Newton
VP Business Development, Inivata
DR CATHERINE ALIXPANABIÈRES PhD-
DR CATHERINE ALIXPANABIÈRES PhD-
Director of the Laboratory Rare Circulating Human Cells (LCCRH), l’Université et CHU de Montpellier, France, Europe
Jennifer Whittington
Jennifer Whittington
Surgical Oncologist, Queens Hospital Cancer Center
Dr. Harsha Doddihal
Dr. Harsha Doddihal
Clinical researcher, Oncologist, Fortis Hospital
Youhe Gao
Youhe Gao
Professor Department of Biochemistry and Molecular Biology, Beijing Normal University
SPONSORS
Leading Partner
example-image

Inivata

example-image

RaDar

Sponsors & Exhibitors
example-image

Indivumed

PAST EVENT GALLERY